• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚维多利亚州对集中式体外膜肺氧合(ECMO)服务的区域访问。

Regional access to a centralized extracorporeal membrane oxygenation (ECMO) service in Victoria, Australia.

作者信息

Chow Joanna Wy, Dyett John F, Hirth Steve, Hart Julia, Duke Graeme J

机构信息

Box Hill Hospital, Eastern Health, VIC, Australia.

Alfred Hospital, Alfred Health, VIC, Australia.

出版信息

Crit Care Resusc. 2023 Dec 13;26(1):47-53. doi: 10.1016/j.ccrj.2023.11.007. eCollection 2024 Mar.

DOI:10.1016/j.ccrj.2023.11.007
PMID:38690191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11056431/
Abstract

INTRODUCTION

Victoria, Australia provides a centralised state ECMO service, supported by ambulance retrieval. Equity of access to this service has not been previously described.

OBJECTIVE

Describe the characteristics of ECMO recipients and quantify geographical and socioeconomic influence on access.

DESIGN

Retrospective observational study with spatial mapping.

PARTICIPANTS AND SETTING

Adult (≥18 years) ECMO recipients from July 2016-June 2022. Data from administrative Victorian Admissions Episodes Database analysed in conjunction with Australian Urban Research Infrastructure Network population data and choropleth mapping. Presumed ECMO modes were inferred from cardiopulmonary bypass and pre-hospital cardiac arrest codes. Spatial autoregressive models including Moran's test used for spatial lag testing.

OUTCOMES

Demographics and outcomes of ECMO recipients; ECMO incidence by patient residence (Statistical-Area Level 2, SA-2) and Index of Relative Socioeconomic Advantage and Disadvantage (IRSAD); and ECMO utilisation adjusted for patient factors and linear distance from the central ECMO referral site.

RESULTS

631 adults received ECMO over 6 years, after exclusion of paediatric (n = 242), duplicate (n = 135), and interstate or incomplete (n = 72) records. Mean age was 51.8 years, and 68.8 % were male. Overall ECMO incidence was 3.00 ± 3.95 per 10 population. 135 (21.4 %) were presumed VA-ECMO, 59 (9.3 %) presumed ECPR, and 437 (69.3 %) presumed VV-ECMO. Spatial lag was non-significant after adjusting for patient characteristics. Distance from the central referral site (dy/dx = 0.19, 95% CI -0.41-0.04, p = 0.105) and IRSAD score (dy/dx = 0.17, 95% CI -0.19-0.53, p = 0.359) did not predict ECMO utilisation.

CONCLUSION

Victorian ECMO incidence rates were low. We did not find evidence of inequity of access to ECMO irrespective of regional area or socioeconomic status.

摘要

引言

澳大利亚维多利亚州提供由救护车转运支持的集中式州级体外膜肺氧合(ECMO)服务。此前尚未描述过该服务的公平可及性。

目的

描述接受ECMO治疗者的特征,并量化地理和社会经济因素对可及性的影响。

设计

采用空间映射的回顾性观察研究。

参与者与研究背景

2016年7月至2022年6月期间接受ECMO治疗的成年(≥18岁)患者。对维多利亚州行政入院病历数据库中的数据,结合澳大利亚城市研究基础设施网络人口数据和分级统计图进行分析。根据体外循环和院前心脏骤停代码推断假定的ECMO模式。使用包括莫兰检验在内的空间自回归模型进行空间滞后检验。

结果

ECMO接受者的人口统计学特征和治疗结果;按患者居住地(统计区2级,SA - 2)和相对社会经济优势与劣势指数(IRSAD)划分的ECMO发病率;以及根据患者因素和距中央ECMO转诊地点的直线距离调整后的ECMO利用率。

结果

排除儿科(n = 242)、重复(n = 135)以及州际或不完整(n = 72)记录后,631名成年人在6年期间接受了ECMO治疗。平均年龄为51.8岁,68.8%为男性。总体ECMO发病率为每10万人3.00±3.95例。135例(21.4%)推测为静脉 - 动脉ECMO,59例(9.3%)推测为体外心肺复苏(ECPR),437例(69.3%)推测为静脉 - 静脉ECMO。在调整患者特征后,空间滞后无统计学意义。距中央转诊地点的距离(dy/dx = 0.19,95%置信区间 - 0.41 - 0.04,p = 0.105)和IRSAD评分(dy/dx = 0.17,95%置信区间 - 0.19 - 0.53,p = 0.359)均不能预测ECMO的利用率。

结论

维多利亚州的ECMO发病率较低。无论地区或社会经济地位如何,我们均未发现ECMO可及性存在不公平的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6c6/11056431/908f78fe1dba/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6c6/11056431/dc87aa2b5c5d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6c6/11056431/908f78fe1dba/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6c6/11056431/dc87aa2b5c5d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6c6/11056431/908f78fe1dba/gr2.jpg

相似文献

1
Regional access to a centralized extracorporeal membrane oxygenation (ECMO) service in Victoria, Australia.澳大利亚维多利亚州对集中式体外膜肺氧合(ECMO)服务的区域访问。
Crit Care Resusc. 2023 Dec 13;26(1):47-53. doi: 10.1016/j.ccrj.2023.11.007. eCollection 2024 Mar.
2
Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort study.体外膜肺氧合治疗 6 个月后澳大利亚患者的病死率或残疾率:一项前瞻性、多中心、登记嵌入式队列研究。
Lancet Respir Med. 2022 Nov;10(11):1038-1048. doi: 10.1016/S2213-2600(22)00248-X. Epub 2022 Sep 26.
3
Extracorporeal membrane oxygenation for critically ill adults.危重症成人的体外膜肺氧合
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010381. doi: 10.1002/14651858.CD010381.pub2.
4
ECMO Cardio-Pulmonary Resuscitation (ECPR), trends in survival from an international multicentre cohort study over 12-years.体外膜肺氧合心肺复苏(ECPR):一项为期12年的国际多中心队列研究中的生存趋势
Resuscitation. 2017 Mar;112:34-40. doi: 10.1016/j.resuscitation.2016.12.009. Epub 2016 Dec 16.
5
Extracorporeal Membrane Oxygenation (ECMO) for Refractory Cardiac Arrest.体外膜肺氧合(ECMO)用于难治性心脏骤停。
J Educ Teach Emerg Med. 2020 Oct 15;5(4):S28-S58. doi: 10.21980/J88W69. eCollection 2020 Oct.
6
Neurological outcomes and duration from cardiac arrest to the initiation of extracorporeal membrane oxygenation in patients with out-of-hospital cardiac arrest: a retrospective study.院外心脏骤停患者体外膜肺氧合启动与心脏骤停至开始之间的神经系统结局和持续时间:一项回顾性研究。
Scand J Trauma Resusc Emerg Med. 2017 Sep 16;25(1):95. doi: 10.1186/s13049-017-0440-7.
7
Prognostic effects of cardiopulmonary resuscitation (CPR) start time and the interval between CPR to extracorporeal cardiopulmonary resuscitation (ECPR) on patient outcomes under extracorporeal membrane oxygenation (ECMO): a single-center, retrospective observational study.体外膜肺氧合(ECMO)下心肺复苏(CPR)开始时间和 CPR 到体外心肺复苏(ECPR)间隔对患者预后的预测作用:一项单中心回顾性观察研究。
BMC Emerg Med. 2024 Mar 5;24(1):36. doi: 10.1186/s12873-023-00905-8.
8
Extracorporeal membrane oxygenation for the treatment of massive pulmonary embolism. An analysis of the ELSO database.体外膜肺氧合治疗大面积肺栓塞。ELSO 数据库分析。
Resuscitation. 2023 Oct;191:109940. doi: 10.1016/j.resuscitation.2023.109940. Epub 2023 Aug 23.
9
Short-term and intermediate outcomes of cardiogenic shock and cardiac arrest patients supported by venoarterial extracorporeal membrane oxygenation.应用体外膜肺氧合支持的心源休克和心脏骤停患者的短期和中期结局。
J Cardiothorac Surg. 2021 Oct 9;16(1):290. doi: 10.1186/s13019-021-01674-w.
10
Extracorporeal membrane oxygenation and Extracorporeal Membrane Oxygenation Cardiopulmonary Resusciation (ECPR) research priorities in Australia: A clinician survey.澳大利亚体外膜肺氧合和体外膜肺氧合心肺复苏(ECPR)研究重点:临床医生调查。
Aust Crit Care. 2023 Sep;36(5):828-831. doi: 10.1016/j.aucc.2022.11.009. Epub 2023 Jan 4.

引用本文的文献

1
Database and geospatial mapping study of those eligible for extracorporeal cardiopulmonary resuscitation in the Thames Valley Region, England.英格兰泰晤士河谷地区符合体外心肺复苏条件者的数据库及地理空间映射研究。
Resusc Plus. 2025 Jan 27;22:100879. doi: 10.1016/j.resplu.2025.100879. eCollection 2025 Mar.

本文引用的文献

1
Disparities in Adult Patient Selection for Extracorporeal Membrane Oxygenation in the United States: A Population-Level Study.美国体外膜肺氧合成人患者选择的差异:一项基于人群的研究。
Ann Am Thorac Soc. 2023 Aug;20(8):1166-1174. doi: 10.1513/AnnalsATS.202212-1029OC.
2
The application of spatial measures to analyse health service accessibility in Australia: a systematic review and recommendations for future practice.空间测度在分析澳大利亚卫生服务可及性中的应用:系统评价及对未来实践的建议。
BMC Health Serv Res. 2023 Apr 1;23(1):330. doi: 10.1186/s12913-023-09342-6.
3
Prognostic factors associated with mortality among patients receiving venovenous extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis.
与 COVID-19 患者接受静脉-静脉体外膜肺氧合治疗相关的死亡预后因素:系统评价和荟萃分析。
Lancet Respir Med. 2023 Mar;11(3):235-244. doi: 10.1016/S2213-2600(22)00296-X. Epub 2022 Oct 10.
4
Association between Availability of Extracorporeal Membrane Oxygenation and Mortality in Patients with COVID-19 Eligible for Extracorporeal Membrane Oxygenation: A Natural Experiment.体外膜肺氧合可用性与符合体外膜肺氧合治疗标准的COVID-19患者死亡率之间的关联:一项自然实验。
Am J Respir Crit Care Med. 2022 Jun 1;205(11):1354-1357. doi: 10.1164/rccm.202110-2399LE.
5
The impact of distance on post-ICU disability.ICU 后残疾的距离影响。
Aust Crit Care. 2022 Jul;35(4):355-361. doi: 10.1016/j.aucc.2021.05.013. Epub 2021 Jul 25.
6
Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study.体外膜肺氧合网络组织与 COVID-19 大流行期间法国大巴黎地区的临床结局:一项多中心队列研究。
Lancet Respir Med. 2021 Aug;9(8):851-862. doi: 10.1016/S2213-2600(21)00096-5. Epub 2021 Apr 19.
7
Extracorporeal Membrane Oxygenation for COVID-19-associated Severe Acute Respiratory Distress Syndrome in Chile: A Nationwide Incidence and Cohort Study.智利针对新型冠状病毒肺炎相关严重急性呼吸窘迫综合征的体外膜肺氧合:一项全国性发病率及队列研究
Am J Respir Crit Care Med. 2021 Jul 1;204(1):34-43. doi: 10.1164/rccm.202011-4166OC.
8
Regional differences in the care and outcomes of acute stroke patients in Australia: an observational study using evidence from the Australian Stroke Clinical Registry (AuSCR).澳大利亚急性脑卒中患者的护理与结局的区域性差异:基于澳大利亚脑卒中临床登记研究(AuSCR)的观察性研究。
BMJ Open. 2021 Apr 1;11(4):e040418. doi: 10.1136/bmjopen-2020-040418.
9
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.COVID-19 患者的体外膜肺氧合支持:体外生命支持组织登记处的国际队列研究。
Lancet. 2020 Oct 10;396(10257):1071-1078. doi: 10.1016/S0140-6736(20)32008-0. Epub 2020 Sep 25.
10
Cross-sectional study for the clinical application of extracorporeal membrane oxygenation in Mainland China, 2018.2018 年中国大陆体外膜肺氧合的临床应用横断面研究。
Crit Care. 2020 Sep 11;24(1):554. doi: 10.1186/s13054-020-03270-1.